All 65 HELX (FRANKLIN GENOMIC ADVANCEMENTS ETF) Holdings
There are 65 HELX holdings. Top 10 companies weight: 47.44%.
Total Market Cap: $2.34T
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (65 stocks) | +19.26% | 35.14 | 24.65 | 0.30 | +16.06% | +20.99% | 0.77 | ||||||||||
1 | GH | Guardant Health Inc | 9.90% | $148.07 | $21B | Diagnostics & Research | Healthcare | +1.05% | N/A | N/A | N/A | N/A | N/A | 77 | +15.54% | $171 | +4.43% | 1.17 |
2 | NTRA | Natera Inc | 7.47% | $262.63 | $40B | Diagnostics & Research | Healthcare | -11.74% | N/A | N/A | N/A | N/A | N/A | 77 | +7.43% | $282 | +17.53% | 1.29 |
3 | KRYS | Krystal Biotech Inc | 6.21% | $339.22 | $10B | Biotechnology | Healthcare | N/A | 45.34 | 46.95 | 0.57 | N/A | N/A | 72 | +6.62% | $362 | +39.91% | 0.92 |
4 | LGND | Ligand Pharmaceuticals Inc | 4.55% | $293.99 | $5.93B | Biotechnology | Healthcare | +26.59% | 37.91 | 34.01 | 1.53 | N/A | N/A | 80 | +5.89% | $311 | +18.82% | 0.96 |
5 | ADPT | Adaptive Biotechnologies Corp | 3.83% | $21.86 | $3.66B | Diagnostics & Research | Healthcare | -22.53% | N/A | N/A | N/A | N/A | N/A | 78 | +0.64% | $22 | -10.55% | 1.70 |
6 | BBIO | Bridgebio Pharma Inc | 3.53% | $80.76 | $16B | Biotechnology | Healthcare | -3.14% | N/A | N/A | N/A | N/A | N/A | 79 | +29.74% | $105 | +5.57% | 1.02 |
7 | UTHR | United Therapeutics Corp | 3.50% | $529.34 | $22B | Drug Manufacturers - Specialty & Generic | Healthcare | +26.56% | 17.96 | 19.49 | 1.91 | N/A | N/A | 75 | +25.34% | $663 | +23.70% | 0.41 |
8 | LLY | Eli Lilly And Co | 2.91% | $1,146.37 | $1.03T | Drug Manufacturers - General | Healthcare | +29.14% | 48.44 | 33.67 | 0.19 | N/A | N/A | 71 | +10.82% | $1.27K | +38.32% | 0.65 |
9 | VRTX | Vertex Pharmaceuticals Inc | 2.84% | $480.50 | $121B | Biotechnology | Healthcare | +9.89% | 27.99 | 25.45 | 1.72 | N/A | N/A | 72 | +15.39% | $554 | +19.61% | 0.49 |
10 | n/a | Astrazeneca Plc | 2.70% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
11 | TWST | Twist Bioscience Corp | 2.67% | $87.45 | $5.76B | Diagnostics & Research | Healthcare | -10.29% | N/A | N/A | N/A | N/A | N/A | 77 | +1.20% | $89 | -6.60% | 2.02 |
12 | TVTX | Travere Therapeutics Inc Ordinary Shares | 2.53% | $55.47 | $5.24B | Biotechnology | Healthcare | -44.12% | N/A | 77.52 | N/A | N/A | N/A | 76 | +5.21% | $58 | +32.19% | 1.28 |
13 | INSM | Insmed Inc | 2.48% | $107.02 | $24B | Biotechnology | Healthcare | +12.24% | N/A | 16.37 | 1.09 | N/A | N/A | 80 | +83.50% | $196 | +32.69% | 0.77 |
14 | CTVA | Corteva Inc | 2.22% | $86.78 | $57B | Agricultural Inputs | Basic Materials | +30.83% | 24.21 | 24.94 | 0.14 | N/A | N/A | 70 | +3.94% | $90 | +16.77% | 0.55 |
15 | n/a | Samsung Biologics Co Ltd | 2.21% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
16 | MEDP | Medpace Holdings Inc | 2.20% | $527.93 | $15B | Diagnostics & Research | Healthcare | +29.42% | 32.55 | 31.95 | 1.67 | N/A | N/A | 57 | -10.53% | $472 | +23.67% | 1.00 |
17 | ALNY | Alnylam Pharmaceuticals Inc | 1.98% | $272.67 | $37B | Biotechnology | Healthcare | N/A | 117.96 | 30.49 | 0.52 | N/A | N/A | 74 | +59.47% | $435 | +8.65% | 0.81 |
18 | TEM | Tempus Ai Inc Class A Common Stock | 1.97% | $48.41 | $10B | Health Information Services | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 65 | +38.53% | $67 | 0.00% | 2.68 |
19 | IONS | Ionis Pharmaceuticals Inc | 1.92% | $52.95 | $9.08B | Biotechnology | Healthcare | -21.44% | N/A | 90.91 | N/A | N/A | N/A | 79 | +75.54% | $93 | +7.60% | 0.65 |
20 | NBIX | Neurocrine Biosciences Inc | 1.86% | $173 | $17B | Drug Manufacturers - Specialty & Generic | Healthcare | +9.25% | 25.72 | 24.10 | 0.21 | N/A | N/A | 75 | +15.75% | $200 | +12.11% | 0.79 |
21 | REGN | Regeneron Pharmaceuticals Inc | 1.83% | $672.15 | $69B | Biotechnology | Healthcare | +20.31% | 15.86 | 15.08 | 88.04 | N/A | N/A | 72 | +21.87% | $819 | +3.03% | 0.60 |
22 | n/a | Argenx Se | 1.62% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
23 | VCYT | Veracyte Inc | 1.55% | $57.26 | $4.75B | Diagnostics & Research | Healthcare | N/A | 53.71 | 34.36 | 0.34 | N/A | N/A | 70 | -1.24% | $57 | +8.04% | 1.36 |
24 | PTCT | Ptc Therapeutics Inc | 1.45% | $78.01 | $6.53B | Biotechnology | Healthcare | -16.59% | N/A | 56.82 | 0.81 | N/A | N/A | 75 | +22.97% | $96 | +12.92% | 0.99 |
25 | BNTX | Biontech Se Adr | 1.41% | $92.16 | $23B | Biotechnology | Healthcare | N/A | N/A | 7.04 | N/A | N/A | N/A | 70 | +32.63% | $122 | -18.34% | 0.94 |
26 | STOK | Stoke Therapeutics Inc | 1.29% | $27.68 | $1.86B | Biotechnology | Healthcare | +11.95% | N/A | 204.08 | N/A | N/A | N/A | 77 | +65.53% | $46 | -3.27% | 1.04 |
27 | n/a | Cash | 1.27% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
28 | CRL | N/A | 1.25% | $219.57 | $11B | Diagnostics & Research | Healthcare | N/A | N/A | 20.16 | N/A | N/A | N/A | 75 | +5.17% | $231 | -10.66% | 1.38 |
29 | GRAL | Grail Inc | 1.07% | $68.91 | $3.06B | Diagnostics & Research | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 61 | +1.76% | $70 | 0.00% | 2.22 |
30 | CRSP | Crispr Therapeutics Ag | 1.05% | $46.99 | $4.95B | Biotechnology | Healthcare | +2.10% | N/A | 23.36 | N/A | N/A | N/A | 70 | +83.46% | $86 | -18.22% | 1.44 |
31 | RGEN | Repligen Corp | 1.00% | $145.49 | $8.35B | Medical Instruments & Supplies | Healthcare | +9.09% | 162.20 | 74.63 | 0.62 | N/A | N/A | 75 | +22.38% | $178 | -6.50% | 1.32 |
32 | ANAB | Anaptysbio Inc | 0.95% | $50.29 | $1.62B | Biotechnology | Healthcare | -4.15% | N/A | N/A | N/A | N/A | N/A | 81 | +73.18% | $87 | +23.70% | 0.80 |
33 | CDNS | Cadence Design Systems Inc | 0.94% | $329.93 | $101B | Software - Application | Technology | +21.45% | 95.54 | 41.67 | 11.28 | N/A | N/A | 77 | +19.66% | $395 | +18.57% | 1.48 |
34 | BEAM | Beam Therapeutics Inc | 0.92% | $26.33 | $3.17B | Biotechnology | Healthcare | -36.45% | N/A | N/A | N/A | N/A | N/A | 73 | +98.67% | $52 | -23.20% | 1.82 |
35 | n/a | Sartorius Ag Participating Preferred | 0.83% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
36 | CDNA | Caredx Inc | 0.81% | $38.37 | $1.53B | Diagnostics & Research | Healthcare | -10.97% | N/A | 94.34 | N/A | N/A | N/A | 60 | -14.00% | $33 | -14.62% | 1.27 |
37 | PRAX | N/A | 0.80% | $304.43 | $8.87B | Biotechnology | Healthcare | -18.18% | N/A | N/A | N/A | N/A | N/A | 75 | +100.39% | $610 | +3.11% | 0.93 |
38 | AXSM | Axsome Therapeutics Inc | 0.80% | $221.64 | $12B | Biotechnology | Healthcare | +6.89% | N/A | 333.33 | N/A | N/A | N/A | 77 | +26.51% | $280 | +31.16% | 0.66 |
39 | IQV | Iqvia Holdings Inc | 0.78% | $203.95 | $35B | Diagnostics & Research | Healthcare | +30.82% | 25.28 | 16.13 | 2.67 | N/A | N/A | 75 | +13.75% | $232 | -3.45% | 1.02 |
40 | JAZZ | Jazz Pharmaceuticals Plc | 0.77% | $243.47 | $15B | Biotechnology | Healthcare | N/A | N/A | 13.51 | 0.96 | N/A | N/A | 78 | +7.51% | $262 | +6.61% | 0.72 |
41 | TMO | Thermo Fisher Scientific Inc | 0.77% | $526.23 | $199B | Diagnostics & Research | Healthcare | +14.94% | 31.53 | 21.41 | 6.52 | N/A | N/A | 74 | +12.36% | $591 | +0.74% | 0.77 |
42 | CPRX | Catalyst Pharmaceuticals Inc | 0.75% | $31.49 | $3.85B | Biotechnology | Healthcare | +20.98% | 17.44 | 12.95 | 1.73 | N/A | N/A | 54 | +0.57% | $32 | +40.70% | 0.87 |
43 | HNGE | N/A | 0.69% | $87.71 | $6.74B | Health Information Services | Healthcare | N/A | N/A | 36.63 | N/A | N/A | N/A | 84 | +1.78% | $89 | 0.00% | 1.27 |
44 | RARE | Ultragenyx Pharmaceutical Inc | 0.60% | $28.53 | $3.12B | Biotechnology | Healthcare | +15.22% | N/A | N/A | N/A | N/A | N/A | 78 | +84.12% | $53 | -19.60% | 0.97 |
45 | DHR | Danaher Corp | 0.58% | $201.52 | $142B | Diagnostics & Research | Healthcare | -4.86% | 38.55 | 24.10 | 1.28 | N/A | N/A | 75 | +20.35% | $243 | -3.53% | 0.79 |
46 | A | Agilent Technologies Inc | 0.56% | $130.27 | $38B | Diagnostics & Research | Healthcare | +10.55% | 26.96 | 19.57 | 1.20 | N/A | N/A | 77 | +22.30% | $159 | -1.95% | 0.96 |
47 | QGEN | Qiagen Nv | 0.48% | $40.48 | $8.51B | Diagnostics & Research | Healthcare | +3.15% | 20.03 | 12.94 | 0.05 | N/A | N/A | 70 | +8.87% | $44 | -4.19% | 0.50 |
48 | RYTM | Rhythm Pharmaceuticals Inc | 0.42% | $104.60 | $7.51B | Biotechnology | Healthcare | +17.00% | N/A | N/A | N/A | N/A | N/A | 79 | +33.59% | $140 | +39.42% | 0.88 |
49 | ARQT | N/A | 0.40% | $27.53 | $3.47B | Biotechnology | Healthcare | -58.89% | N/A | 158.73 | N/A | N/A | N/A | 78 | +25.75% | $35 | +0.98% | 1.24 |
50 | n/a | Samsung Epis Holdings Co Ltd | 0.35% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
HELX (FRANKLIN GENOMIC ADVANCEMENTS ETF) Sector Allocation
HEALTHCARE
88.30%MATERIALS
2.20%INFORMATION TECHNOLOGY
0.90%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%UTILITIES
0.00%ENERGY
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%